Aberrant methylation of hMLH1 and p16INK4a in Tunisian patients with sporadic colorectal adenocarcinoma.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Bioscience Reports

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BSR20100023PMID 20815811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.

  2009cited by this paper
• Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers

  2009cited by this paper
• CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

  2008cited by this paper
• CpG Island Methylator Phenotype Associates with Low-Degree Chromosomal Abnormalities in Colorectal Cancer

  2008cited by this paper
• Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions.

  2008cited by this paper
• p16INK4a Gene Promoter Hypermethylation in Mucosa as a Prognostic Factor for Patients with Colorectal Cancer

  2008cited by this paper
• Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value.

  2007cited by this paper
• Epigenetic changes (aberrant DNA methylation) in colorectal neoplasia.

  2007cited by this paper
• Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

  2006cited by this paper
• [Cancer epigenetics].

  2006cited by this paper
• Epigenetic events in the colorectum and in colon cancer.

  2005cited by this paper
• TNM Atlas : Illustrated Guide to the TNM Classification of Malignant Tumours

  2005cited by this paper
• p16 Gene Methylation in Colorectal Tumors: Correlation with Clinicopathological Features and Prognostic Value

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Epigenetic changes in colorectal cancer

  2004cited by this paper
• Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.

  2004cited by this paper
• BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency

  2003cited by this paper
• Differences in loss of p16INK4 protein expression by promoter methylation between left- and right-sided primary colorectal carcinomas.

  2003cited by this paper
• Cancer epigenetics

  2003cited by this paper
• Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.

  2003cited by this paper
• Methylation of hMLH1 promoter correlates with the gene silencing with a region-specific manner in colorectal cancer

  2002cited by this paper
• [Assessment of cancer incidence in Tunisia 1993-1997].

  2002cited by this paper
• Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status

  2002cited by this paper
• Mutations of the BRAF gene in human cancer

  2002cited by this paper
• K-ras and p16 aberrations confer poor prognosis in human colorectal cancer.

  2001cited by this paper
• p16 gene methylation in colorectal cancers associated with Duke's staging.

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Mutations, methylation and expression of CDKN2a/p16 gene in colorectal cancer and normal colonic mucosa.

  2001cited by this paper
• Methylation of the hMLH1, p16, and MDR1 genes in colorectal carcinoma: associations with clinicopathological features.

  2001cited by this paper
• The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis.

  2000cited by this paper
• Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer.

  1999cited by this paper
• CpG island methylator phenotype in colorectal cancer.

  1999cited by this paper
• Hypermethylation of the p16 Gene in Sporadic T3N0M0 Stage Colorectal Cancers: Association with DNA Replication Error and Shorter Survival

  1999cited by this paper
• Aging and DNA methylation in colorectal mucosa and cancer.

  1998cited by this paper
• A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

  1998cited by this paper
• Role of the p16 tumor suppressor gene in cancer.

  1998cited by this paper
• Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression.

  1997cited by this paper
• Genetic instability in colorectal cancers

  1997cited by this paper
• Association between CpG island methylation and microsatellite instability in colorectal cancer.

  1997cited by this paper
• Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines.

  1997cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Microsatellite instability in cancer of the proximal colon.

  1993cited by this paper

• Identification and external validation of tumor DNA methylation panel for the recurrence risk stratification of stage II colon cancer

  2025cites this paper
• Large-scale external validation and meta-analysis of gene methylation biomarkers in tumor tissue for colorectal cancer prognosis

  2024cites this paper
• Caracterización molecular de pacientes con cáncer colorrectal

  2022cites this paper
• Methylation-Based Therapies for Colorectal Cancer

  2020cites this paper
• The Relevance of Gender in Tumor-Influencing Epigenetic Traits

  2019cites this paper
• Methylation Status of p16 gene in Iraqi Colorectal Cancer Patients

  2019cites this paper
• DNA Mismatch Repair Protein Immunohistochemistry and MLH1 Promotor Methylation Testing for Practical Molecular Classification and the Prediction of Prognosis in Endometrial Cancer

  2018cites this paper
• Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review

  2018cites this paper
• Promoter methylation of human mutL homolog 1 and colorectal cancer risk: A meta-analysis

  2018cites this paper
• The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging

  2018cites this paper
• Clinical and prognosis value of the CIMP status combined with MLH1 or p16INK4a methylation in colorectal cancer

  2017cites this paper
• Relationship Between Human mutL Homolog 1 (hMLH1) Hypermethylation and Colorectal Cancer: A Meta-Analysis

  2017influential citation
• Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma.

  2017cites this paper
• Expression and promoter DNA methylation of MLH1 in colorectal cancer and lung cancer.

  2017cites this paper
• Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis in colorectal cancer patients with microsatellite instability tumors

  2015cites this paper
• Relationships Between p16 Gene Promoter Methylation and Clinicopathologic Features of Colorectal Cancer: A Meta-Analysis of 27 Cohort Studies

  2014cites this paper
• Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance

  2014cites this paper
• Prognostic significance of hMLH1/hMSH2 gene mutations and hMLH1 promoter methylation in sporadic colorectal cancer

  2014cites this paper
• Prognostic Value of p16 Promoter Hypermethylation in Colorectal Cancer: A Meta-Analysis

  2014cites this paper
• Clinicopathological Comparison of Adenocarcinoma of Cervix and Endometrium Using Cell Cycle Markers: P16ink4a, P21waf1, and p27Kip1 on 132 Cancers

  2011influential citation
• Expression of p16INK4a, Alone or Combined With p53, is Predictive of Better Prognosis in Colorectal Adenocarcinoma in Tunisian Patients

  2011cites this paper